GONADOTROPIN-RELEASING HORMONE AGONISTS IN UTERINE MYOMA

Download full text PDF
Issue: 
5
Year: 
2016

Professor A. Khardikov (1), MD, Academician of the Russian Academy of Natural Sciences; A. Klimkin (2); S. Petrov (2), Candidate of Medical Sciences 1 -Kursk State Medical University 2 -OOO Avicenna Medical Center, Kursk

The gonadotropin-releasing hormone agonist Buserelin Long has been shown to be effective in the medical treatment of uterine myoma and to improve outcomes of organ-sparing surgery.
Keywords: 
Buserelin Long
gonadotropin-releasing hormone agonists
uterine myoma

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Bakanova A.R., Gubajdullin A.R. Agonisty gonadotropin-rilizing gor monov v hirurgicheskom lechenii submukozno-interstitsial'nyh miom matki // Elektronnyj nauchno-obrazovatel'nyj vestnik zdorov'e i obrazovanie v XXI veke. – 2009; 11 (10): 422–3.
  2. Bujanova S.N. Miomektomija vne i vo vremja beremennosti: pokazanija, osobennosti hirurgicheskoj taktiki i anestezii, predoperatsionnaja podgo-tovka i reabilitatsija // Ros. vestn. akushera-ginekologa. – 2013; 13 (2): 95–100.
  3. Zhujko A.A., Kompaniets O.G. Lejomioma matki: farmakoekonomicheskaja effektivnost' lekarstvennyh preparatov, umen'shajuschih razmer miomatoz-nyh uzlov // Kubanskij nauchn. med. vest. – 2010; 2: 33–6.
  4. Litsova A.O., Peretjatko L.P., Malyshkina A.I. Kliniko- morfologicheskaja harakteristika bystrorastuschej miomy matki pri leche-nii patsientok agonistami gonadotropnyh rilizing-gormonov // Medicus. – 2015; 3 (3): 19–22.
  5. Samojlova T.E., Kulumbegova L.T., Smetnik V.P. Effektivnost' ana logov gonadotropin-rilizing gormona (agonistov i antagonistov) pri lechenii lejomiomy matki // Vestn. RUDN (Ser. Meditsina). – 2005; 4: 216–27.
  6. Smirnova T.A., Mal'tsevich O.V. Rasshirenie vozmozhnostej konserva-6. tivnogo lechenija miomy matki // Med. zhurn. – 2014; 2 (48): 108–11.
  7. Tihomirov A.L. Agonisty gonadotropnyh rilizing-gormonov v lechenii miomy matki // Rus. med. zhurn. – 2010; 18 (4): 188–91.
  8. Tihomirov A.L. Sovremennye printsipy terapevticheskogo lechenija miomy matki // Effektivnaja farmakoter. – 2015; 5: 56–60.
  9. Churilov A.V., Melehina L.M., Deev E.A. Klinicheskij opyt primenenija preparata ljukrin-depo dlja lechenija bol'nyh s lejomiomoj matki // Vestnik neotlozhnoj i vosstanovitel'noj meditsiny. – 2011; 12 (2): 207–9.
  10. Bifulco G., Miele C., Pellicano M. Molecular mechanism, involved in GnRG analogue related apoptosis for uterine leiomyomas // Mol. Hum. Reprod. – 2004; 10 (1): 43–8.
  11. Chegini N., Corvberg L., Gonadotropin-releasing hormones analogue therapy alter signal transduction pathways involving mitogen activated protein and focal adhesion kinases in leiomyomas // J. Soc. Gynecol. Investig. – 2003; 10 (1): 21–6.
  12. Chegini N., Lui X., Ding L. et al. The expression of smads and transforming growth factor beta receptors in leiomyoma and myometriumand the effect of gonadotropin releasing hormones analogue therapy // Mol. Cel. Endocrinol. – 2003; 209 (1–2): 9–16
  13. De Lieto A., De Falco M., Pollio F. Clinical response, vascular change and 13. angiogenesis in gonadotropin releasing analogue treated women with uterine myomas // J. Soc. Gynecol. Investig. – 2005; 12 (2): 123–8.
  14. Shindler A. Gonadotropin-releasing agonists for preventing of postoperative adhesions: an overview // Gynecol. Endocrinol. – 2004; 7 (5): 1951–5.